Mortality News and Research

RSS

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Cancer rates falling in the US

The nation's leading cancer organizations report that Americans' risk of getting and dying from cancer continues to decline and survival rates for many cancers continue to improve.

3 Jun 2004

Dire health consequences for millions of people in Darfur, Sudan

The World Health Organization (WHO) has warned of dire health consequences for millions of people in Darfur, Sudan. A significant increase in disease and death is inevitable without a rapid increase in external help.

3 Jun 2004

Pollution can contribute to the development of cardiovascular diseases

Journal of the American Heart Association reports that exposure to air pollution can contribute to the development of cardiovascular diseases.

2 Jun 2004

FDA clears first computer-aided device to assist in the detection of heart murmurs

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.

2 Jun 2004

Women with chest pain who have low hemoglobin levels are more likely to die or suffer a heart attack

Women with chest pain who have low hemoglobin levels are more likely to die or suffer a heart attack, heart failure, stroke or other cardiovascular event than women with normal hemoglobin levels, according to a new study in the June 2, 2004 issue of the Journal of the American College of Cardiology.

2 Jun 2004

Chronic diseases are the largest cause of death in the world

The rising global burden of chronic diseases needs a coordinated effort from policy makers, advocates and health professionals, according to a special communication in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.

1 Jun 2004

Higher rate of cancer in meat industry

A study of over 6600 meat industry workers around New Zealand has found a significantly high rate of cancers, particularly lung cancer, which may be caused by exposure to cancer causing agents carried by animals.

31 May 2004

Vermont announces free or discounted nicotine patches and gum

Free or discounted nicotine replacement therapy (NRT) - nicotine patches and gum - will be provided for a limited time to all adult Vermonters who want to quit smoking cigarettes, thanks to a significant expansion of the Vermont Department of Health's NRT program announced.

31 May 2004

Breast reduction instead of removal a viable breast cancer alternative

Women at high risk of developing breast cancer may have an additional preventative alternative to having their breasts removed – breast reduction surgery, according to a study published in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

31 May 2004

Tobacco-related illnesses costs Ilinois $6.7 billion annually

Tobacco-related illnesses take the lives of more than 16,500 Illinois residents each year and cost the state $6.7 billion annually in medical care and lost productivity, according to Dr. Eric E. Whitaker, state public health director.

27 May 2004

Weight loss medication Xenical® more effective than lifestyle changes alone in managing weight

The weight loss medication Xenical® (orlistat) has been shown to be significantly more effective than lifestyle changes alone in managing weight in overweight adolescents, according to new study results presented today at ECO2004, Prague, Czech Republic.

27 May 2004

ACE inhibitors for diabetics cut in half the risk of death

ACE inhibitors, a type of medication often used to treat high blood pressure or heart disease, can lower mortality rates for people who have diabetes -- whether they have cardiovascular disease or not, according to a study published in the June issue of Diabetes Care.

26 May 2004

In the years between adolescence and adulthood, about three men die for every woman

In the years at the dangerous border between adolescence and adulthood, about three men die for every woman, according to a new University of Michigan study of the ratio of male to female mortality rates in 20 nations, including the United States.

25 May 2004

New findings suggest mammograms may help predict cardiovascular disease

The presence of breast vascular calcifications found through common mammograms is associated with an increased risk of cardiovascular diseases in women, according to an article in the May Journal of Women's Health.

25 May 2004

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

UI Heart Care researchers are among the first in the nation to evaluate the effectiveness of cardiac resynchronization therapy (CRT) devices to reduce the risk of mortality and hospitalization in advanced heart failure patients.

25 May 2004

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

“Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it,” says Mariell Jessup, MD, Professor of Medicine and Medical Director of the Heart Failure and Transplantation Program at the Hospital of the University of Pennsylvania (HUP).

24 May 2004

Among older people, diabetes substantially increases premature deaths

A new study involving tens of thousands of people 65 and older suggests that even among older people, diabetes substantially increases premature deaths, according to researchers at Wake Forest University Baptist Medical Center.

24 May 2004

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Vertex Pharmaceuticals Incorporated has announced that it has expanded its drug discovery and development collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.

24 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Mortality News and Research

Drug Tarceva improves survival chance for patients with advanced lung cancer

Cancer rates falling in the US

Dire health consequences for millions of people in Darfur, Sudan

Pollution can contribute to the development of cardiovascular diseases

FDA clears first computer-aided device to assist in the detection of heart murmurs

Women with chest pain who have low hemoglobin levels are more likely to die or suffer a heart attack

Chronic diseases are the largest cause of death in the world

Higher rate of cancer in meat industry

Vermont announces free or discounted nicotine patches and gum

Breast reduction instead of removal a viable breast cancer alternative

Tobacco-related illnesses costs Ilinois $6.7 billion annually

Weight loss medication Xenical® more effective than lifestyle changes alone in managing weight

ACE inhibitors for diabetics cut in half the risk of death

In the years between adolescence and adulthood, about three men die for every woman

New findings suggest mammograms may help predict cardiovascular disease

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

Among older people, diabetes substantially increases premature deaths

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News